Guangzhou Yipinhong Pharmaceutical CO.,LTD
Quick facts
Marketed products
- Clindamycin palmitate hydrochloride dispersible tablet
- Fuganlin Oral Liquid
- PNA · Infectious diseases
PNA is a type of antimicrobial peptide that works by disrupting bacterial cell membranes. - Xiaoer Jiebiao Oral Liquid · Pediatrics / Infectious Disease
Xiaoer Jiebiao Oral Liquid is a traditional Chinese medicine formulation that promotes fever resolution and supports immune function in pediatric patients.
Phase 2 pipeline
- Alprostadil Liposomes for Injection · Cardiovascular
vasodilation via prostaglandin E1 receptor agonism
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Guangzhou Yipinhong Pharmaceutical CO.,LTD portfolio CI brief
- Guangzhou Yipinhong Pharmaceutical CO.,LTD pipeline updates RSS
Frequently asked questions about Guangzhou Yipinhong Pharmaceutical CO.,LTD
What are Guangzhou Yipinhong Pharmaceutical CO.,LTD's marketed drugs?
Top marketed products include Clindamycin palmitate hydrochloride dispersible tablet, Fuganlin Oral Liquid, PNA, Xiaoer Jiebiao Oral Liquid.
Related
- Clindamycin palmitate hydrochloride dispersible tablet
- Fuganlin Oral Liquid
- PNA · Infectious diseases
- Xiaoer Jiebiao Oral Liquid · Pediatrics / Infectious Disease
- Sector hub: All tracked pharma companies